Our shared journey in a dynamic industry
For nearly a decade, we, as brothers, have been leading Cansativa through an industry that is constantly evolving—especially on the regulatory front. In a sensitive field like medical cannabis, which is still in the early stages of medical application, it is important to us to take responsibility and advocate for greater transparency and destigmatization.
Medical cannabis has been prescribable in Germany since 2017 and can be reimbursed by health insurance for seriously ill patients. Since then, there have been continuous adjustments that have simplified the prescription process for patients and helped advance the destigmatization of this form of treatment. At the same time, scientific research is steadily growing, more therapeutic uses are being incorporated into guidelines, and more countries across Europe and worldwide recognize medical cannabis as an effective therapy. We are proud to have actively helped shape this development in Europe and especially in Germany from the beginning, even though there is still much work to be done.
A modern family business with a course toward Europe
Cansativa is not a traditional family business that has been passed down through generations. Instead, as brothers, we took a bold step in 2017 together with our father to realize our dream of founding a joint business: Our father supported us in the beginning, providing medical expertise and backing. Jakob, as a lawyer, decided to navigate and actively shape the complex regulatory environment, while Benedikt, with his background as a strategy consultant, drives business development and growth. Today, as a family-scale-up in the German Mittelstand, we are building the infrastructure for a safe, responsible, and digital cannabis market in Europe—with clear values, regulatory depth, and technological precision. Our goal is to make Germany a hub for medical cannabis.
A strong signal for the European cannabis industry
Alongside renowned companies from the fields of industry, technology, tourism, and mobility, this nomination shows that the cannabis economy is also one of the forces actively shaping progress and responsibility in Europe. We are very pleased with this recognition—it is a powerful signal of the relevance and future viability of our industry.
A huge thank you to our team, our partners, and everyone who supports our mission.
The public voting is open until September 1, 2025, and we would be delighted if you support us with your vote.
Please vote for us! Click here to vote!